Intravenous Zanamivir for Oseltamivir-Resistant 2009 H1N1 Influenza
- 7 January 2010
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 362 (1) , 88-89
- https://doi.org/10.1056/nejmc0910893
Abstract
A 10-year-old girl with acute lymphoblastic leukemia was transferred to our hospital on August 31. The patient required mechanical ventilation for worsening lobar pneumonia, despite the administration of broad-spectrum antibiotics (for details, see the Supplementary Appendix, available with the full text of this letter at NEJM.org). Two weeks earlier, she had completed 5 days of oseltamivir for an upper respiratory tract infection caused by influenza A virus (with positive results on rapid antigen testing). On August 27, she had presented with lobar pneumonia (with negative results on rapid antigen testing).Keywords
This publication has 3 references indexed in Scilit:
- Rapid Antigen Tests for Diagnosis of Pandemic (Swine) Influenza A/H1N1Clinical Infectious Diseases, 2009
- H1N1 pneumonitis treated with intravenous zanamivirThe Lancet, 2009
- Safety and Efficacy of Intravenous Zanamivir in Preventing Experimental Human Influenza A Virus InfectionAntimicrobial Agents and Chemotherapy, 1999